Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Research nurses in the NHS are playing a crucial role in helping to trial new coronavirus treatments and vaccines. Three NDS research nurses stepped up to help with the fight against this new disease. Here Bhumika Patel shares her experience of working on the Oxford COVID-19 Vaccine Trial.

A vaccine being injected into a woman's upper arm

I supported with the recruitment process of participants in the COVID-19 Phase II/III Vaccine Study as a Research Nurse. The trial is jointly run by the Oxford Vaccine Group (Department of Paediatrics) and Jenner Vaccine Trials team (Nuffield Department of Medicine) at the Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital. 

Many people volunteered for the study and many healthcare workers were required to help. Jane NiedererKatherine Gordan-Quayle and I initially helped with screening, ensuring that participants were eligible and safe to take part. The study visits included gaining informed consent, which was ongoing as the protocol developed, and taking bloods samples. Other responsibilities included preparation of the blinded vaccine and observation of participants post vaccination. 

Participants' appointments were back-to-back. Each participant had different requirements depending on the arm or group they were allocated to, so we all had to be meticulous and vigilant! Recruitment completed in early December 2020 and participants will be followed up to a year after vaccination, which I will continue to help with. It was a huge combined effort of many teams, from medical students to lab and admin staff, to make this vaccine possible. 

It was very exciting to put my research experience and skills to use during the first lockdown and I will continue to work on the new upcoming COVID-19 trials

Medicines from clinical trials usually take many years to become licenced. Personally, it was truly amazing to see the analysis as the study rolled out and to receive the Oxford-Astra-Zeneca COVID-19 vaccine myself! 

I couldn't work as a front-line nurse, so it was very exciting to put my research experience and skills to use during the first lockdown and I will continue to work on the new upcoming COVID-19 trials with the Oxford Vaccine Group in 2021.  

Bhumika has recently started a new position as Clinical Research Nurse at the Oxford Respiratory Trials Unit.

Blog posts

My half marathon challenge to help support those living with dementia

Zoe Uttley, Executive Officer to the Director of SITU NDS and SITU NDS Coordinator, is preparing to run the Oxford Half Marathon on Sunday 13 October 2024 in support of Alzheimer's Society. Read her story.

Running for CRIS Cancer Foundation

NDS researcher Dimitrios Doultsinos is preparing to run the Athens Authentic Marathon and the Royal Parks Half in support of CRIS Cancer Foundation.

Developing myself through an HR apprenticeship

HR Officer Claire Wheeler, who is completing an HR apprenticeship at NDS, has been featured in the Abingdon & Witney College Apprenticeship Newsletter. Read her interview below.

Joanna Hester shares her 'Collaboration in Action' story

Joanna Hester is an Associate Professor at NDS. In her collaboration story, Joanna shares her motivations and experiences in collaborating with various industry partners, starting from her post-doctoral days participating in EU-funded projects to her current role as a Principal Investigator.

The ethical impacts of international medical electives on local students and patient care

Magdalena Chmura, a former Student Rep of Oxford University Global Surgery Group and current Foundation Year doctor shares a paper recently published with Dr Shobhana Nagraj.